Travere Therapeutics
TVTX
#4846
Rank
C$1.89 B
Marketcap
$21.30
Share price
-9.48%
Change (1 day)
125.70%
Change (1 year)

P/S ratio for Travere Therapeutics (TVTX)

P/S ratio as of April 2025 (TTM): 5.78

According to Travere Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.8. At the end of 2024 the company had a P/S ratio of 6.45.

P/S ratio history for Travere Therapeutics from 2011 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.4538.67%
20234.65-35.69%
20227.23-13.42%
20218.3516.34%
20207.18105.76%
20193.49-38.81%
20185.706.69%
20175.35-0.03%
20165.35-24.07%
20157.04-37.71%
201411.3
2013N/A
2012N/A
2011N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
92.5 1,500.03%๐Ÿ‡บ๐Ÿ‡ธ USA
1.75-69.80%๐Ÿ‡บ๐Ÿ‡ธ USA